← Eichor
Study identifier: NCT07483216 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effects of a Isokinetic Exercise in Women With Fibromyalgia

Condition: Fibromyalgia (FM)  ·  Sponsor: European University Miguel de Cervantes

PhaseNA
Planned participants36
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

Fibromyalgia is a chronic syndrome characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and functional impairment, which significantly affects quality of life. Physical exercise is considered one of the most effective non-pharmacological interventions for the management of this condition; however, uncertainty remains regarding the most appropriate type, intensity, and frequency of exercise for different patient profiles. The aim of this study is to analyze the effects of a microdoses isokinetic exercise program on physical condition, perceived pain, inflammatory profile and quality of life in women diagnosed with fibromyalgia.

This description comes directly from the study's public registry record.

Talk to the study team

Alejandro Santos Lozano, PhD  ·  0034983001000  ·  asantos@uemc.es

Sergio Maroto Izquierdo, PhD  ·  0034983001000  ·  smaroto@uemc.es

Always discuss trial participation with your own doctor first.

Locations (1)

Miguel de Cervantes European UniversityValladolid, Valladolid, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07483216